CAMDEN ASSET MANAGEMENT L P /CA - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AD2. A total of 40 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CAMDEN ASSET MANAGEMENT L P /CA ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$24,314,850
+454.4%
24,900,000
+435.5%
0.90%
+494.7%
Q2 2023$4,385,531
+3.9%
4,650,0000.0%0.15%
+7.8%
Q1 2023$4,219,875
+6.3%
4,650,000
+8.1%
0.14%
+10.2%
Q4 2022$3,969,437
-6.6%
4,300,0000.0%0.13%
-10.5%
Q3 2022$4,249,000
+8.7%
4,300,0000.0%0.14%
+18.2%
Q2 2022$3,910,0004,300,0000.12%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 127,800,000$128,518,0002.56%
WOLVERINE ASSET MANAGEMENT LLC 107,030,000$106,622,0001.15%
MACKAY SHIELDS LLC 24,472,000$24,283,0000.61%
SSI INVESTMENT MANAGEMENT LLC 6,945,000$6,865,0000.46%
ADVENT CAPITAL MANAGEMENT /DE/ 20,000,000$19,863,0000.36%
TENOR CAPITAL MANAGEMENT Co., L.P. 15,500,000$15,433,0000.35%
Magnetar Financial LLC 16,700,000$16,606,0000.23%
CAMDEN ASSET MANAGEMENT L P /CA 4,300,000$4,249,0000.14%
CAPSTONE INVESTMENT ADVISORS, LLC 18,700,000$18,571,0000.11%
RWC Asset Management LLP 2,500,000$2,497,0000.08%
View complete list of IONIS PHARMACEUTICALS INC shareholders